期刊文献+

老年女性骨质疏松症患者药物治疗现况调查 被引量:2

Investigation of Quo Status on Drug Treatment in Elderly Osteoporosis Women
下载PDF
导出
摘要 目的:调查老年女性骨质疏松症(OP)患者药物治疗的现状,寻找提高老年女性OP患者临床疗效的方法。方法:对172例老年女性OP患者的用药情况进行调查,并分析用药情况与血清骨转换标志物(BTMs)的关系。结果:老年女性OP患者药物治疗率很低,仅为36.05%。接受过抗OP药物治疗的老年女性OP患者的3个BTMs水平均明显低于未接受过药物治疗的患者,差异有统计学意义(P<0.001);坚持(≥12月)抗OP药物治疗老年女性的3个BTMs水平均明显低于未坚持(<12月)治疗的患者,差异有统计学意义(P<0.05)。结论:加强OP防治知识的宣传,提高OP患者的用药依从性,可能是提高老年女性OP患者临床治疗效果的重要方法。 Objective : To probe into the way to heighten clinic therapeutic effect by means of investigating current status of drug treatment in elderly osteoporosis women, nethods:A cross-sectional survey was conducted comprising a sample of 172 elderly osteoporosis women. All of subjects underwent questionnaire survey and monitoring of bone turnover markers ( BTMs), and the relationship between pharmacy and BTMs was analyzed. Results: The rate of drug treatment was only 36.05% in elderly osteoporosis women. The lever of BTMs were significantly lower in elderly osteoporosis women who had accepted drug treatment than who hadn' t ( P 〈 0. 001 ) ; and the ones were significantly lower in elderly osteoporosis women who had persisted to accept drug treatment ( I〉 12 month) than who hadn't ( 〈 12 month) (P 〈 0.05 ). Conclusion:The probable ways to improve clinic therapeutic effect in elderly osteoporosis women were to strengthen publicity and education of osteoporosis knowledge, and to improve medication adherence.
出处 《药物流行病学杂志》 CAS 2016年第11期719-721,共3页 Chinese Journal of Pharmacoepidemiology
基金 浙江省医药卫生平台重点资助项目(编号:2016ZDA002) 浙江省人民医院优秀青年人员科研启动基金(编号:zry2015C002)
关键词 骨质疏松症 药物 骨转换标志物 老年女性患者 Osteoporosis Drug Bone turnover markers Woman Aged
  • 相关文献

参考文献8

二级参考文献52

  • 1张智海,沈建雄,刘忠厚.DXA骨密度仪在国内标一化回顾性研究[J].中国骨质疏松杂志,2005,11(2):133-139. 被引量:7
  • 2骨质疏松及骨矿盐疾病诊疗指南(讨论稿)[J].国际内分泌代谢杂志,2006,26(4):291-298. 被引量:47
  • 3刘广源,邱贵兴,吴志宏.使用NORLAND骨密度仪比较不同人种峰值骨量值[J].中国骨质疏松杂志,2007,13(2):101-104. 被引量:8
  • 4Srinivasan B,Kopperdahl D L,Amin S. Relationship of femoral neck areal bone mineral density to volumetric bonemineral density,bone size,and femoral strength in men and women[J].Osteoporosis International,2012,(01):155-162. 被引量:1
  • 5de Castro Gomes D A,Valadares A L,Pinto-Neto A M. Ability to fol ow drug treatment with calcium and vitamin D in postmenopausalwomen with reduced bone mass[J].MENOPAUSE-THE Journal OF THE NORTH AMERICAN MENOPAUSE SOCIETY,2012,(09):989-994. 被引量:1
  • 6Hosam K. Underutilization of calcium and vitamin D supplements in an academic long-term care facility[J].Journal of the American Medical Directors Association,2004,(01):98-100. 被引量:1
  • 7Pilz S,Dobnig H,Tomaschitz A. Low 25-hydroxyvitamin D is associated with increased mortality in female nursing home residents[J].Journal of Clinical Endocrinology and Metabolism,2012,(04):653-657. 被引量:1
  • 8Joergensen C,Reinhard H,Schmedes A. Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate[J].Diabetes Care,2012,(01):168-172. 被引量:1
  • 9McClung M,Harris S T,Mil er P D. Bisphosphonate therapy for osteoporosis:benefits,risks,and drug holiday[J].American Journal of Medicine,2013,(01):13-20. 被引量:1
  • 10Puah K L,Tan M H. Bisphosphonate-associated atypical fracture of the femur:Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures--a case report[J].ACTA ORTHOPAEDICA,2011,(03):380-382. 被引量:1

共引文献2019

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部